Atlas Trials

Orelabrutinib With R-CHOP-like Regimen for Patients With Newly Diagnosed Untreated Non-GCB DLBCL

Clinical trial NCT05498259 · UNKNOWN

Trial details

NCT number
NCT05498259
Sponsor
The First Affiliated Hospital of Soochow University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Diffuse Large B-Cell Lymphoma
Start date
2022-07-27
Primary completion
2024-01-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.